ChAdOx1 nCoV-19 Vaccine Side Effects among Healthcare Workers in Trinidad and Tobago

Vaccine hesitancy due to safety concerns is a hindrance to the success of vaccination campaigns. In February 2021, Trinidad and Tobago commenced its National COVID-19 Vaccination Program. Healthcare workers were among the first group to receive the ChAdOx1 nCoV-19 (Oxford–AstraZeneca (Covishield, Se...

Descripción completa

Detalles Bibliográficos
Autores principales: Gopaul, Chavin D., Ventour, Dale, Thomas, Davlin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953927/
https://www.ncbi.nlm.nih.gov/pubmed/35335098
http://dx.doi.org/10.3390/vaccines10030466

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953927/
https://www.ncbi.nlm.nih.gov/pubmed/35335098
http://dx.doi.org/10.3390/vaccines10030466

Ejemplares similares